S. B. Ross

发表

Evidence for a role of the locus coeruleus noradrenaline system in learning

T. Archer, S. Ögren, S. Ross, 1980, Neuroscience Letters.

Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat.

S. Ross, A. L. Renyi, S. B. Ross, 2009, Acta pharmacologica et toxicologica.

Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.

K. Fuxe, C. Köhler, S. Ross, 1981, European Journal of Pharmacology.

(Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake.

S. Ross, S. Ogren, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

Structural Requirements for Uptake into Serotoninergic Neurones

S. Ross, A. Ask, S. B. Ross, 2009 .

Behavioral Pharmacology of AR-A000002, a Novel, Selective 5-Hydroxytryptamine1B Antagonist

T J Hudzik, J. Evenden, C. Ryan, 2003, Journal of Pharmacology and Experimental Therapeutics.

Substituted amphetamine derivatives. II. Behavioural effects in mice related to monoaminergic neurones.

S. Ross, S. Ogren, Sven Ove Ögren, 2009, Acta pharmacologica et toxicologica.

Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram

S. Ross, C. Stenfors, H. Yu, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT

S. Ross, B. Svensson, L. Rényi, 1990, Neuropharmacology.